Enliven Therapeutics Banner Image

Enliven Therapeutics

  • Ticker ELVN
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Enliven Therapeutics Logo Image
  • 11-50 Employees
  • Based in Boulder, Colorado
Enliven Therapeutics is a biopharmaceutical company focused on the discovery and development of small molecule inhibitors to help patients with cancer live not only longer, but better. Enliven aims to address existing and emerging unmet needs with a precision oncology approach that improves survival and enhances overall patient well-being. Enliven’s discovery process combines deep insightsMore from clinically validated biological targets and differentiated chemistry to design potentially first-in-class or best-in-class therapies.
Enliven Therapeutics

Most Recent Annual Report

Enliven Therapeutics
MOST RECENT 2022 Annual Report and Form 10K

Older/Archived Annual Reports

Enliven Therapeutics Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!